Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Dow
Johnson and Johnson
Baxter
Colorcon
Merck
Boehringer Ingelheim

Last Updated: November 30, 2022

Meclizine hydrochloride - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


What are the generic sources for meclizine hydrochloride and what is the scope of freedom to operate?

Meclizine hydrochloride is the generic ingredient in two branded drugs marketed by Casper Pharma Llc, Invagen Pharms, Ivax Sub Teva Pharms, Nexgen Pharma Inc, Pliva, Abc Holding, Amneal Pharms, Anabolic, Ani Pharms, Apnar Pharma Lp, Aurobindo Pharma Usa, Bundy, Epic Pharma Llc, Indicus Pharma, Invatech, Jubilant Cadista, Kv Pharm, Lupin Ltd, Rising, Sandoz, Strides Pharma, Superpharm, UDL, Vangard, Watson Labs, and Zydus, and is included in thirty-eight NDAs. Additional information is available in the individual branded drug profile pages.

There are nine drug master file entries for meclizine hydrochloride. Thirty-four suppliers are listed for this compound.

Summary for meclizine hydrochloride
Recent Clinical Trials for meclizine hydrochloride

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Mansoura UniversityPhase 1/Phase 2
Hospital Federal de BonsucessoPhase 4
Yvonne SadaPhase 1

See all meclizine hydrochloride clinical trials

Pharmacology for meclizine hydrochloride
Drug ClassAntiemetic
Physiological Effect Emesis Suppression
Medical Subject Heading (MeSH) Categories for meclizine hydrochloride

US Patents and Regulatory Information for meclizine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Anabolic MECLIZINE HYDROCHLORIDE meclizine hydrochloride TABLET;ORAL 085891-001 Approved Prior to Jan 1, 1982 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Strides Pharma MECLIZINE HYDROCHLORIDE meclizine hydrochloride TABLET;ORAL 089674-001 Mar 31, 1988 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Bundy MECLIZINE HYDROCHLORIDE meclizine hydrochloride TABLET;ORAL 084872-001 Approved Prior to Jan 1, 1982 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Ani Pharms MECLIZINE HYDROCHLORIDE meclizine hydrochloride TABLET;ORAL 085269-001 Approved Prior to Jan 1, 1982 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Casper Pharma Llc ANTIVERT meclizine hydrochloride TABLET;ORAL 010721-006 Approved Prior to Jan 1, 1982 AA RX Yes No See Plans and Pricing See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Baxter
McKinsey
McKesson
Boehringer Ingelheim
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.